Advertisement

Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

  • Matthew H. Slawson
  • Kamisha L. Johnson-DavisEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1383)

Abstract

Carisoprodol and meprobamate are centrally acting muscle relaxant/anxiolytic drugs that can exist in a parent–metabolite relationship (carisoprodol → meprobamate) or as a separate pharmaceutical preparation (meprobamate aka Equanil, others). The monitoring of the use of these drugs has both clinical and forensic applications in pain management applications and in overdose situations. LC-MS/MS is used to analyze urine or plasma/serum extracts with deuterated analogs of each analyte as internal standards to ensure accurate quantitation and control for any potential matrix effects. Positive ion electrospray is used to introduce the analytes into the mass spectrometer. Selected reaction monitoring of two product ions for each analyte allows for the calculation of ion ratios which ensures correct identification of each analyte, while a matrix-matched calibration curve is used for quantitation.

Key words

Carisoprodol Meprobamate Muscle relaxant Mass spectrometry 

References

  1. 1.
    Tse SA, Atayee RS, Ma JD, Best BM (2014) Factors affecting carisoprodol metabolism in pain patients using urinary excretion data. J Anal Toxicol 38(3):122–128. doi: 10.1093/jat/bku002 CrossRefPubMedGoogle Scholar
  2. 2.
    McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL (2013) Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management. J Pain Palliat Care Pharmacother 27(4):322–339. doi: 10.3109/15360288.2013.847889 CrossRefPubMedGoogle Scholar
  3. 3.
    Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14(5):332–334CrossRefPubMedGoogle Scholar
  4. 4.
    Gaillard Y, Billault F, Pepin G (1997) Meprobamate overdosage: a continuing problem. Sensitive GC-MS quantitation after solid phase extraction in 19 fatal cases. Forensic Sci Int 86(3):173–180CrossRefPubMedGoogle Scholar
  5. 5.
    Daval S, Richard D, Souweine B, Eschalier A, Coudore F (2006) A one-step and sensitive GC-MS assay for meprobamate determination in emergency situations. J Anal Toxicol 30(5):302–305CrossRefPubMedGoogle Scholar
  6. 6.
    Baselt RC (2011) Disposition of toxic drugs and chemicals in man, 9th edn. Biomedical Publications, Seal Beach, CAGoogle Scholar
  7. 7.
    Alvarez JC, Duverneuil C, Zouaoui K, Abe E, Charlier P, de la Grandmaison GL, Grassin-Delyle S (2012) Evaluation of the first immunoassay for the semi-quantitative measurement of meprobamate in human whole blood or plasma using biochip array technology. Clin Chim Acta 413(1–2):273–277. doi: 10.1016/j.cca.2011.10.025 CrossRefPubMedGoogle Scholar
  8. 8.
    Coulter C, Garnier M, Tuyay J, Orbita J Jr, Moore C (2012) Determination of carisoprodol and meprobamate in oral fluid. J Anal Toxicol 36(3):217–220. doi: 10.1093/jat/bks009 CrossRefPubMedGoogle Scholar
  9. 9.
    Essler S, Bruns K, Frontz M, McCutcheon JR (2012) A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 908:155–160. doi: 10.1016/j.jchromb.2012.09.001 CrossRefPubMedGoogle Scholar
  10. 10.
    Sreenivasulu V, Ramesh M, Kumar IJ, Babu RV, Pilli NR, Krishnaiah A (2013) Simultaneous determination of carisoprodol and aspirin in human plasma using liquid chromatography-tandem mass spectrometry in polarity switch mode: application to a human pharmacokinetic study. Biomed Chromatogr 27(2):179–185. doi: 10.1002/bmc.2766 CrossRefPubMedGoogle Scholar
  11. 11.
    Bevalot F, Gustin MP, Cartiser N, Gaillard Y, Le Meur C, Fanton L, Guitton J, Malicier D (2013) Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes. Int J Leg Med 127(5):915–921. doi: 10.1007/s00414-013-0833-8 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Matthew H. Slawson
    • 2
    • 3
  • Kamisha L. Johnson-Davis
    • 1
    Email author
  1. 1.Department of PathologyUniversity of Utah Health Sciences Center, School of Medicine, ARUP Institute for Clinical and Experimental PathologySalt Lake CityUSA
  2. 2.ARUP Institute for Clinical and Experimental PathologySalt Lake CityUSA
  3. 3.ARUP LaboratoriesSalt Lake CityUSA

Personalised recommendations